fluticasone propionate + loratadine

Fluticasone propionate + loratadine is a combination of two pharmaceutical agents commonly used for the treatment of allergic rhinitis and related allergy symptoms. Fluticasone propionate is a synthetic corticosteroid that acts as an anti-inflammatory agent, primarily by inhibiting multiple types of inflammatory cells and mediators involved in the allergic response. Loratadine is a second-generation antihistamine that selectively antagonizes peripheral histamine H1 receptor, reducing symptoms such as sneezing, runny nose, and itchy or watery eyes. The combination aims to provide both anti-inflammatory effects (from fluticasone) and rapid antihistaminic relief (from loratadine), potentially offering greater symptom control than either agent alone[2][4][5]. Both drugs are well-tolerated with low incidence of adverse effects.